Gout: On the brink of novel therapeutic options for an ancient disease

Saved in:
Bibliographic Details
Published inArthritis and rheumatism Vol. 50; no. 8; pp. 2400 - 2414
Main Authors Bieber, Jeffry D., Terkeltaub, Robert A.
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.08.2004
Subjects
Acute Disease
Benzothiadiazines
Diuretics
Female
Gout - drug therapy
Gout - etiology
Gout - therapy
Humans
Hypertension - complications
Hyperuricemia - drug therapy
Kidney Diseases - complications
Metabolic Syndrome - complications
Obesity - complications
Postmenopause
Sodium Chloride Symporter Inhibitors - adverse effects
Urate Oxidase - therapeutic use
Uric Acid - metabolism
Uricosuric Agents - therapeutic use
Xanthine Oxidase - antagonists & inhibitors
Online AccessGet full text

Cover

More Information
Bibliography:Dr. Terkeltaub is a paid consultant to Novartis, East Hanover, NJ, and TAP Pharmaceuticals, Lake Forest, IL.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-2
ISSN:0004-3591
1529-0131
DOI:10.1002/art.20438